Elite Pharma Inc (ELTP)
Elite Pharma Inc. is a healthcare company focused on pharmaceuticals and listed on OTC Markets as common stock. The company develops, manufactures, and sells oral and controlled-release medicines, including generic and branded products. Its business includes work under generic drug applications and branded drug applications, covering therapies used in areas such as bariatrics, pain management, cardiovascular disease, central nervous system disorders, muscle relaxation, antipsychotic treatment, and antibiotics. Elite also performs contract manufacturing of controlled-release products for third parties and is developing abuse-deterrent opioid candidates. Incorporated in 1997, the company is headquartered in Northvale, New Jersey.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-ELTP
|
$0.46
|
23.0% Upside
|
Undervalued
|
—
|
—
|
—
|
Excellent
|
—
|
—
|
—
|
0.0%
|
August 17, 2026
|
9.1x
|
4.1x
|
2.7x
|
414.7 M
|
384.3 M
|
1.4%
|
77.6%
|
8.6
|
—
|
50.9%
|
